Why the Weight Comes Back: What Happens After Stopping GLP-1 Drugs

People who take semaglutide or tirzepatide often lose a lot of weight while on the drugs. The tricky part is figuring out what happens after they stop taking them. A new analysis looked closely at how quickly the weight tends to come back.

Researchers gathered data from six studies covering 1,776 participants. They tracked weight changes for anywhere from 4 to 52 weeks after treatment ended. Using a Bayesian statistical model, they worked out a few key numbers. On average, people had lost about 15.35 kilograms by the time they stopped the medication. After that, the weight crept back on at roughly 1.04 kilograms per month.

Based on that monthly pace, the model predicted people would regain half of what they had lost within around seven and a half months. A full return to the starting weight was projected by about 15 months. These later numbers come from mathematical projections rather than direct observation, so they carry some uncertainty.

The analysis also tested what might speed up or slow down the regain. Tirzepatide users appeared to gain weight back a bit faster than semaglutide users in raw numbers, but once the model adjusted for other factors, that difference faded. Losing a larger amount of weight up front showed the clearest link to faster regain, though the data was not tight enough to call it a sure thing. Having a behavioural or lifestyle support program after stopping the drug trended toward slower regain, but again, the evidence was not strong enough to be certain.

The big picture is straightforward. When people stop these medications, the weight tends to return quickly and meaningfully. Because the longer-term estimates rely on modeling rather than real-world tracking, doctors and patients should treat them as educated guesses. Planning ahead with early monitoring and a solid maintenance strategy seems like a sensible move once treatment ends.